JP2013507912A - Composition for improving blood circulation and improving cooling of hands and feet containing fermented tea extract - Google Patents

Composition for improving blood circulation and improving cooling of hands and feet containing fermented tea extract Download PDF

Info

Publication number
JP2013507912A
JP2013507912A JP2012534120A JP2012534120A JP2013507912A JP 2013507912 A JP2013507912 A JP 2013507912A JP 2012534120 A JP2012534120 A JP 2012534120A JP 2012534120 A JP2012534120 A JP 2012534120A JP 2013507912 A JP2013507912 A JP 2013507912A
Authority
JP
Japan
Prior art keywords
tea
bacillus
fermented
fermented tea
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012534120A
Other languages
Japanese (ja)
Other versions
JP6355887B2 (en
Inventor
ジュン シン、ヒョン
ジン イ、ブン
ウン イ、ジ
ジン オ、ユ
オ チョン、ジン
バン ソ、デ
ジュン イ、サン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of JP2013507912A publication Critical patent/JP2013507912A/en
Application granted granted Critical
Publication of JP6355887B2 publication Critical patent/JP6355887B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby
    • A23F3/14Tea preparations, e.g. using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

本発明は、茶(tea)に醤類由来の菌株を接種して得られた発酵茶、及び前記発酵茶を製造する方法を開示する。前記発酵茶は、味と香りに優れ、優れた血液循環改善効果及び手足冷え性改善効果を示し、健康食品又は医薬品分野において多様に活用可能である。The present invention discloses a fermented tea obtained by inoculating tea with a strain derived from soy sauce, and a method for producing the fermented tea. The fermented tea is excellent in taste and aroma, exhibits excellent blood circulation improvement effect and limb cooling effect improvement, and can be used in various fields in the health food or pharmaceutical field.

Description

本発明は、発酵茶抽出物を有効成分として含有する血液循環改善用及び手足冷え性改善用組成物に関する。   The present invention relates to a composition for improving blood circulation and improving the ability to cool hands and feet, which contains a fermented tea extract as an active ingredient.

緑茶を例とする様々な種類の茶が昔から嗜好品として広く知られている。そのうち緑茶は、葉茶の形態で飲用されたりもするが、より深い香りを楽しむために発酵茶として飲用されたりもする。たとえば、発酵緑茶は、発酵の形態及び程度に応じて、緑茶、烏龍茶、紅茶、プーアル茶等のような多様な名称で呼ばれる。発酵茶は、葉茶と比較すると、香りに違いが現れるだけでなく、発酵過程において多様な程度に変化した有効成分を有し得る。   Various types of tea, such as green tea, have been widely known as a luxury item for a long time. Among them, green tea is sometimes drunk in the form of leaf tea, but is also drunk as fermented tea to enjoy a deeper aroma. For example, fermented green tea is called by various names such as green tea, oolong tea, black tea, puer tea, etc., depending on the form and degree of fermentation. Compared with leaf tea, fermented tea not only shows a difference in aroma, but may have active ingredients that have changed to various degrees during the fermentation process.

一方、現代人は、脂肪の摂取機会及び摂取量が多くなったのに反して運動量は不足し、多種多様なストレスを受けて生きている。こうした生活パターンの変化は、多様な種類の成人病を誘発し、特に、血液循環障害といった循環器系疾患の発病頻度を高める。血液循環障害は、手足のしびれ、慢性疲労、めまい及び無気力症等の症状を誘発して正常な生活を営むことを困難にし、ひどい場合には、高脂血症、動脈硬化、狭心症といった多様な疾病に発展し得る。一般的に、軽度の血液循環障害は看過されやすい。しかし、年齢を重ねるにつれて、血液循環障害は深刻化する傾向を示す。特に、更年期の女性の場合には、手足のしびれ等により苦しむケースが増加している。   On the other hand, modern people live with a variety of stresses due to lack of exercise, despite the increased opportunity and intake of fat. Such changes in lifestyle patterns induce various types of adult diseases, and in particular, increase the incidence of cardiovascular diseases such as impaired blood circulation. Blood circulatory disturbances induce symptom such as numbness of limbs, chronic fatigue, dizziness and lethargy, making it difficult to live a normal life. In severe cases, such as hyperlipidemia, arteriosclerosis, angina Can develop into various diseases. In general, mild blood circulation disorders are easily overlooked. However, with increasing age, blood circulation disorders tend to become more serious. In particular, women who are menopause are increasingly suffering from numbness in their limbs.

本発明の発明者らは発酵過程の違いによる茶の効能についての研究を実施し、特に、茶を利用して血液循環を効果的に促進し、ひいては手足冷え性を改善することのできる方案を講じようとした。   The inventors of the present invention have conducted research on the efficacy of tea due to differences in fermentation processes, and in particular, have proposed a method that can effectively promote blood circulation using tea and thus improve the cooling of hands and feet. I tried.

本発明の一側面は、味と香りに優れた発酵茶を提供しようとするものである。
本発明の他の一側面は、血液循環改善用組成物を提供しようとするものである。
本発明の他の一側面は、手足冷え性改善用組成物を提供しようとするものである。
One aspect of the present invention is to provide a fermented tea excellent in taste and aroma.
Another aspect of the present invention is to provide a composition for improving blood circulation.
Another aspect of the present invention is to provide a composition for improving limb cooling properties.

本発明の他の一側面は、発酵茶の製造方法を提供しようとするものである。   Another aspect of the present invention is to provide a method for producing fermented tea.

本発明の一側面は、茶(tea)に醤類由来の菌株を接種して得られた発酵茶を提供する。
本発明の他の一側面は、茶(tea)含有発酵液を製造する工程;製造された発酵液に醤類由来の菌株を接種する工程;及び、菌株が接種された発酵液を発酵させる工程を含む発酵茶の製造方法を提供する。
One aspect of the present invention provides a fermented tea obtained by inoculating tea with a soy-derived strain.
Another aspect of the present invention is a step of producing a tea-containing fermentation broth; a step of inoculating a soy-derived strain into the produced fermentation broth; and a step of fermenting the fermentation broth inoculated with the strain. A method for producing fermented tea comprising

本発明の一側面に係る発酵茶は、味と香りに優れ、優れた血液循環改善効果を示し、健康食品又は医薬品分野において多様に活用可能である。   The fermented tea according to one aspect of the present invention is excellent in taste and aroma, exhibits an excellent blood circulation improvement effect, and can be used in various fields in the health food or pharmaceutical field.

発酵茶の摂取後の時間経過に伴う手の温度変化を示したグラフである。It is the graph which showed the temperature change of the hand with the time passage after ingestion of fermented tea. 発酵茶の摂取後の時間経過に伴う手の温度変化を示した赤外線撮影写真である。It is the infrared photography photograph which showed the temperature change of the hand with the time passage after ingestion of fermented tea. 発酵茶の摂取後の時間経過に伴う足の温度変化を示したグラフである。It is the graph which showed the temperature change of the leg with time progress after ingestion of fermented tea. 発酵茶の摂取後の時間経過に伴う足の温度変化を示した赤外線撮影写真である。It is the infrared photography photograph which showed the temperature change of the leg | foot with time passage after ingestion of fermented tea. 発酵茶の摂取後の嗜好感に関する設問調査の結果を表したグラフである。It is a graph showing the result of the question investigation about the taste after ingestion of fermented tea.

本発明の一側面に係る組成物は、茶(tea)成分に醤類由来の菌株を接種して一定時間発酵させて得られた発酵茶を特徴とする。
前記茶(tea)の種類は、特に制限されず、緑茶、白茶、烏龍茶、紅茶、プーアル茶、黒茶、柿葉茶の他、多様な種類のハーブ茶等を含む。本発明の一側面において、前記茶は、緑茶、白茶、烏龍茶、紅茶、プーアル茶、黒茶及び柿葉茶により構成される群から選択される一つ以上の茶であってよい。他の一側面において、前記茶は緑茶であってよい。
The composition according to one aspect of the present invention is characterized by fermented tea obtained by inoculating a tea component with a strain derived from soy sauce and fermenting it for a certain period of time.
The type of tea (tea) is not particularly limited, and includes various types of herbal teas in addition to green tea, white tea, oolong tea, black tea, puer tea, black tea, kashiwa tea, and the like. In one aspect of the present invention, the tea may be one or more teas selected from the group consisting of green tea, white tea, oolong tea, black tea, puer tea, black tea and kashiwa tea. In another aspect, the tea may be green tea.

また、前記醤類由来の菌株は、麹を利用して製造される醤油、味噌若しくは唐辛子味噌に由来する菌株、又は豆を利用して製造される納豆由来の菌株であってよい。前記醤類由来の菌株は、たとえば、バチルス・サブティリス(Bacillus subtilis)、バチルス・リケニフォルミス(Bacillus licheniformis)、バチルス・メガテリウム(Bacillus megateriums)、バチルス・ナットウ(Bacillus natto)、バチルス・シトレウス(Bacillus citreus)、バチルス・サーキュランス(Bacillus circulans)、バチルス・メセンテリカス(Bacillus mesentericus)及びバチルス・プミルス(Bacillus pumilus)により構成される群から選択される一つ又は二つ以上の菌株であってよい。前記醤類由来の菌株は、好ましくは、バチルス・サブティリス(Bacillus subtilis)であってよく、これは枯草菌とも呼ばれる。バチルス・サブティリスは、アミラーゼ、プロテアーゼ、アミノ酸、抗微生物製剤(antibacterial compound)又は界面活性剤等の生産に利用されている。特に、バチルス・サブティリスは、ヒト、動物及び植物等において毒性を示さないため、食品微生物として広く利用されている。   The soy sauce-derived strain may be a soy sauce produced using koji, a strain derived from miso or chili miso, or a natto-derived strain produced using beans. Examples of the strains derived from the soy sauce include Bacillus subtilis, Bacillus licheniformis, Bacillus megateriums, Bacillus citrus (Bacillus natto) One or more strains selected from the group consisting of Bacillus circulans, Bacillus mesentericus and Bacillus pumilus. The soy-derived strain may preferably be Bacillus subtilis, also called Bacillus subtilis. Bacillus subtilis is used for production of amylase, protease, amino acid, antibacterial compound or surfactant. In particular, Bacillus subtilis is widely used as a food microorganism because it does not show toxicity in humans, animals, plants, and the like.

本発明に係る「発酵茶」は、発酵した状態の茶(tea)を意味するものであり、茶の原料又は発酵の程度の異なる多様な茶をすべて包括する概念である。たとえば、前記「発酵茶」は、発酵の程度に応じて、部分発酵茶、強発酵茶及び後発酵茶等をすべて含む。   “Fermented tea” according to the present invention means a tea in a fermented state (tea), and is a concept encompassing all of various teas having different raw materials or fermentation levels. For example, the “fermented tea” includes partially fermented tea, strong fermented tea, post-fermented tea, and the like depending on the degree of fermentation.

本発明は、また、前記発酵茶を製造する方法を提供する。本発明の一側面に係る発酵茶の製造方法は、茶(tea)成分に醤類由来の菌株を接種した後、一定時間発酵させて発酵茶を製造することができる。本発明に係る一側面において、前記発酵茶は、茶(tea)成分を含有した発酵液を製造する工程;製造された発酵液に醤類由来の菌株を接種する工程;及び、菌株が接種された発酵液を発酵させる工程を含んでいてよい。   The present invention also provides a method for producing the fermented tea. The method for producing fermented tea according to one aspect of the present invention can produce fermented tea by inoculating a tea (tea) component with a strain derived from soy sauce and then fermenting it for a certain time. In one aspect of the present invention, the fermented tea is a step of producing a fermentation broth containing a tea (tea) component; a step of inoculating a soy-derived strain into the produced fermentation broth; A step of fermenting the fermented liquid.

前記茶(tea)の種類は、特に制限されず、緑茶、白茶、烏龍茶、紅茶、プーアル茶、黒茶、柿葉茶等や、多様な種類のハーブ茶等を含む。本発明に係る一側面において、前記茶は、緑茶、白茶、烏龍茶、紅茶、プーアル茶、黒茶及び柿葉茶により構成される群から選択される一つ以上の茶であってよい。他の一側面において、前記茶は緑茶であってよい。   The type of the tea is not particularly limited, and includes green tea, white tea, oolong tea, black tea, puer tea, black tea, kashiwa tea, and various kinds of herbal teas. In one aspect of the present invention, the tea may be one or more teas selected from the group consisting of green tea, white tea, oolong tea, black tea, puer tea, black tea and kashiwa tea. In another aspect, the tea may be green tea.

前記醤類由来の菌株は、麹を使用して製造される醤油、味噌若しくは唐辛子味噌に由来する菌株、又は豆を利用して製造される納豆由来の菌株とすることができる。前記醤類由来の菌株は、たとえば、バチルス・サブティリス(Bacillus subtilis)、バチルス・リケニフォルミス(Bacillus licheniformis)、バチルス・メガテリウム(Bacillus megateriums)、バチルス・ナットウ(Bacillus natto)、バチルス・シトレウス(Bacillus citreus)、バチルス・サーキュランス(Bacillus circulans)、バチルス・メセンテリカス(Bacillus mesentericus)及びバチルス・プミルス(Bacillus pumilus)により構成される群から選択される一つ又は二つ以上の菌株であってよい。   The soy sauce-derived strain can be a soy sauce produced using koji, a strain derived from miso or chili miso, or a natto-derived strain produced using beans. The soy sauce-derived strains include, for example, Bacillus subtilis, Bacillus licheniformis, Bacillus megateriums, Bacillus citrus, Bacillus natto, One or more strains selected from the group consisting of Bacillus circulans, Bacillus mesentericus and Bacillus pumilus.

また、菌株が接種された発酵液を発酵させる工程は、14時間〜28日間を所要してよい。前記発酵温度は、20〜70℃、具体的には40〜60℃であってよい。発酵温度が40℃を超えると、バチルス・サブティリス菌を除く他の菌は生育が抑制されるか死滅するという効果がある。しかし、発酵温度が過度に高くなると、バチルス・サブティリス菌の生育を阻害し得る。   Moreover, the process of fermenting the fermentation liquid inoculated with the strain may require 14 hours to 28 days. The fermentation temperature may be 20 to 70 ° C, specifically 40 to 60 ° C. When fermentation temperature exceeds 40 degreeC, there exists an effect that other microbes except a Bacillus subtilis microbe will suppress growth or die. However, if the fermentation temperature is excessively high, the growth of Bacillus subtilis can be inhibited.

本発明の一側面に係る発酵茶の製造方法を、より具体的に説明すると、次のとおりである。
まず、培養されたバチルス・サブティリス(Bacillus subtilis)菌株を発酵液に接種する。前記発酵液は、微生物に対する水分とエネルギーの供給源となるものであり、たとえば、発酵液の総重量を基準にして、2.0〜3.0重量%の砂糖及び果糖を混合し、大豆粉等を添加して製造することができる。その後、接種された菌株の発酵代謝の円滑化のために、菌株が接種された発酵液を培養器で培養する過程に供してもよい。次に、緑茶を発酵液に混合して発酵させる。混合される発酵液の比率は、緑茶茶葉の乾燥重量を基準にして、10〜80重量%が適切である。発酵は、20〜70℃の恒温発酵槽において、24時間から28日間実施することができる。発酵が完了した後、熱風乾燥を通じて乾燥する過程をさらに施しもよい。
The method for producing fermented tea according to one aspect of the present invention will be described in more detail as follows.
First, the cultured solution is inoculated with a Bacillus subtilis strain. The fermented liquor is a source of moisture and energy for microorganisms. For example, based on the total weight of the fermented liquor, 2.0-3.0 wt% sugar and fructose are mixed, soy flour Etc. can be added. Thereafter, in order to facilitate the fermentation metabolism of the inoculated strain, the fermented liquid inoculated with the strain may be subjected to a process of culturing in an incubator. Next, green tea is mixed with the fermentation broth and fermented. The ratio of the fermented liquid to be mixed is suitably 10 to 80% by weight based on the dry weight of green tea leaves. Fermentation can be carried out in a constant temperature fermentor at 20 to 70 ° C. for 24 hours to 28 days. After the fermentation is completed, a process of drying through hot air drying may be further performed.

本発明の一側面は、前記発酵茶の抽出物を提供する。本発明の一側面において、発酵が完了した発酵茶は、多様な方法を通じて抽出することができる。発酵茶の抽出物は、たとえば、熱水抽出物又はC〜Cの低級アルコール抽出物であってよいが、特に制限されるものではなく、具体的には、熱水抽出物であってよい。前記発酵茶の抽出物は、多様な形態での製剤化が可能である。 One aspect of the present invention provides an extract of the fermented tea. In one aspect of the present invention, fermented tea that has been fermented can be extracted through various methods. Extract of fermented tea may be, for example, a lower alcohol extract of hot water extract or C 1 -C 5, but is not particularly limited, specifically, a hot water extract Good. The fermented tea extract can be formulated in various forms.

本発明の一側面は、前記発酵茶の抽出物を含む血液循環改善用組成物を提供する。たとえば、前記血液循環改善用組成物は、茶(tea)成分にバチルス・サブティリス菌株を接種して得られた発酵茶を多様な方法で抽出して得られた抽出物を有効成分として含むことができる。前記血液循環改善用組成物は、醤類由来の菌株を用いて発酵された発酵茶の成分を含有することにより、血清及び肝臓のコレステロールと中性脂肪を減少させ、血管の収縮を抑制する。したがって、前記組成物は、血液循環を改善し、高脂血症又は手足冷え性等の症状を好転させる効果がある。   One aspect of the present invention provides a composition for improving blood circulation comprising the extract of the fermented tea. For example, the composition for improving blood circulation contains, as an active ingredient, an extract obtained by extracting fermented tea obtained by inoculating a tea (tea) component with a Bacillus subtilis strain by various methods. Can do. The composition for improving blood circulation contains components of fermented tea fermented using a soy sauce-derived strain, thereby reducing serum and liver cholesterol and neutral fat, and suppressing blood vessel contraction. Therefore, the composition has an effect of improving blood circulation and improving symptoms such as hyperlipidemia or coldness of hands and feet.

本発明の他の一側面は、前記発酵茶の抽出物を含む手足冷え性改善用組成物を提供する。たとえば、前記手足冷え性改善用組成物は、緑茶にバチルス・サブティリス菌株を接種して得られた発酵茶の抽出物を有効成分として含んでいてよい。前記組成物は、味と香りに優れ、血液の循環を改善して手足冷え性等の症状を改善する効果がある。   Another aspect of the present invention provides a composition for improving cooling of hands and feet, comprising the extract of fermented tea. For example, the composition for improving limb cooling property may contain an extract of fermented tea obtained by inoculating green tea with a Bacillus subtilis strain as an active ingredient. The composition is excellent in taste and aroma, and has the effect of improving blood circulation and improving symptoms such as coldness of hands and feet.

また、本発明の他の一側面は、前記発酵茶の抽出物を含有する食品添加剤、健康食品及び医薬品等を提供する。たとえば、前記発酵茶の抽出物は、丸剤、カプセル剤、錠剤、顆粒剤又はドリンク剤等に剤形化して、健康食品、医薬品等に使用することができる。また、他の一側面において、別途の抽出過程に供していない発酵茶は、液剤、粉末、顆粒、錠剤又はティーバッグ等の形態に加工し、又は葉茶本来の形態で製剤化することができる。たとえば、緑茶葉の発酵茶はティーバッグの形態に加工することができる。前記発酵茶又は発酵茶の抽出物を含有する組成物は、血液や肝臓の脂質を減少させ、血管の収縮を抑制して血管の弛緩を誘導することにより、血液循環を改善する効果がある。たとえば、前記発酵茶又は発酵茶の抽出物を含有する組成物は、手足冷え性改善用組成物であってよい。   Another aspect of the present invention provides food additives, health foods, pharmaceuticals, and the like containing the fermented tea extract. For example, the fermented tea extract can be formulated into pills, capsules, tablets, granules or drinks and used for health foods, pharmaceuticals, and the like. In another aspect, fermented tea that has not been subjected to a separate extraction process can be processed into a liquid, powder, granule, tablet, tea bag, or the like, or formulated in the original form of leaf tea. . For example, fermented tea of green tea leaves can be processed into a tea bag form. The composition containing the fermented tea or the extract of fermented tea has an effect of improving blood circulation by reducing blood and liver lipids and suppressing blood vessel contraction to induce blood vessel relaxation. For example, the composition containing the fermented tea or the extract of fermented tea may be a composition for improving the cooling of hands and feet.

本発明の他の一側面は、前記発酵茶の抽出物を含む多様な形態の食品添加剤又は機能性食品を提供する。例えば、前記発酵茶の抽出物は、発酵乳、チーズ、ヨーグルト、ジュース、プロバイオティクス食品及び健康食品等の食品のための添加剤に含まれてもよいが、これらに限定されず、多様な食品添加剤に含まれていてよい。   Another aspect of the present invention provides various forms of food additives or functional foods containing the fermented tea extract. For example, the extract of the fermented tea may be included in an additive for foods such as fermented milk, cheese, yogurt, juice, probiotic foods, and health foods, but is not limited thereto. It may be contained in food additives.

本発明の一側面において、前記発酵茶の抽出物は、本発明が目的とする主たる効果を損なわない範囲内において、主たる効果に相乗効果を与え得る他の成分等を含有していてよい。たとえば、物理的性質の改善のために、香料、色素、殺菌剤、酸化防止剤、防腐剤、保湿剤、増粘剤、無機塩類、乳化剤及び合成高分子物質等の添加剤をさらに含んでいてよい。その他にも、水溶性ビタミン、油溶性ビタミン、高分子ペプチド、高分子多糖及び海藻エキス等の補助成分をさらに含むこともできる。これらの成分は、剤形又は使用目的に応じて、当業者が困難なく適宜に選定して配合することができ、その添加量は、本発明の目的及び効果を損なわない範囲内で選択することができる。たとえば、これらの成分の添加量は、組成物全体の重量を基準にして、0.01〜5重量%、より具体的には、0.01〜3重量%の範囲であってよい。   In one aspect of the present invention, the extract of fermented tea may contain other components that can give a synergistic effect to the main effect within a range that does not impair the main effect of the present invention. For example, to improve physical properties, it further includes additives such as fragrances, pigments, bactericides, antioxidants, preservatives, moisturizers, thickeners, inorganic salts, emulsifiers and synthetic polymer substances. Good. In addition, auxiliary components such as water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, and seaweed extracts can be further included. These components can be appropriately selected and blended without difficulty by those skilled in the art according to the dosage form or purpose of use, and the addition amount should be selected within a range that does not impair the purpose and effect of the present invention. Can do. For example, the amount of these components added may range from 0.01 to 5% by weight, more specifically from 0.01 to 3% by weight, based on the weight of the entire composition.

本発明の一側面に係る発酵茶の抽出物は、溶液、乳化物、粘性混合物、タブレット、粉末等の多様な形態で剤形化することができ、これは、飲用、注射、スプレー又はスクイーズ等の多様な方法で投与することができる。   The extract of fermented tea according to one aspect of the present invention can be formulated into various forms such as a solution, an emulsion, a viscous mixture, a tablet, a powder, and the like, such as drinking, injection, spray or squeeze Can be administered in various ways.

本発明の一側面は、また、前記発酵茶の抽出物を含む医薬組成物を提供する。前記医薬組成物は、血液循環改善効果を示す。
本発明の一側面に係る発酵茶の抽出物を医薬品に適用する場合、前記抽出物を有効成分とし、無機又は有機の通常の担体を加えて、固体、半固体又は液状の形態で経口投与剤或いは非経口投与剤に製剤化することができる。
One aspect of the present invention also provides a pharmaceutical composition comprising the fermented tea extract. The pharmaceutical composition exhibits an effect of improving blood circulation.
When the extract of fermented tea according to one aspect of the present invention is applied to a pharmaceutical product, the extract is used as an active ingredient, an inorganic or organic normal carrier is added, and an oral administration agent in a solid, semi-solid or liquid form Alternatively, it can be formulated into a parenteral administration agent.

前記経口投与剤としては、錠剤、丸剤、顆粒剤、軟質及び硬質カプセル剤、散剤、細粒剤、粉剤、乳濁剤、シロップ剤、ペレット剤等が挙げられる。また、前記非経口投与剤としては、注射剤、点滴剤、軟膏、ローション、スプレー、懸濁剤、乳剤、坐剤等が挙げられる。本発明の有効成分は、常法に従って容易に製剤化することができ、界面活性剤、賦形剤、着色料、香辛料、保存料、安定剤、緩衝剤、懸濁剤、その他通常の補助剤を適当に使用することができる。   Examples of the oral administration agent include tablets, pills, granules, soft and hard capsules, powders, fine granules, powders, emulsions, syrups, pellets and the like. Examples of the parenteral administration agent include injections, drops, ointments, lotions, sprays, suspensions, emulsions, suppositories and the like. The active ingredient of the present invention can be easily formulated according to a conventional method, and includes surfactants, excipients, colorants, spices, preservatives, stabilizers, buffers, suspending agents, and other usual auxiliary agents. Can be used appropriately.

本発明に係る前記医薬組成物は、経口投与、非経口投与、直腸投与、局所投与、経皮投与、静脈内投与、筋肉内投与、腹腔内投与、皮下投与等ができる。
また、前記有効成分の投与量は、治療を受ける対象の年齢、性別及び体重、治療する特定の疾患又は病理状態、疾患又は病理状態の深刻度、投与経路、並びに処方者の判断によって変わるであろう。これらの要因に基づいて投与量を決定することは当業者の範疇にある。一般的な投与量は、0.001mg/kg/日〜2000mg/kg/日、より具体的には、0.5mg/kg/日〜1500mg/kg/日である。
The pharmaceutical composition according to the present invention can be administered orally, parenterally, rectally, topically, transdermally, intravenously, intramuscularly, intraperitoneally, subcutaneously, and the like.
The dosage of the active ingredient may vary depending on the age, sex and weight of the subject to be treated, the specific disease or pathological condition to be treated, the severity of the disease or pathological condition, the route of administration, and the judgment of the prescriber. Let's go. It is within the scope of those skilled in the art to determine dosages based on these factors. Typical dosages are 0.001 mg / kg / day to 2000 mg / kg / day, more specifically 0.5 mg / kg / day to 1500 mg / kg / day.

以下、下記の実施例を通じて本発明をより詳細に説明することとする。ただし、下記の実施例は、本発明を例示するためのものであるに過ぎず、本発明の範囲がこれらによって限定されるものではない。   Hereinafter, the present invention will be described in more detail through the following examples. However, the following examples are only for illustrating the present invention, and the scope of the present invention is not limited thereto.

[実施例1]発酵茶の製造
振動培養器を利用して30℃で72時間培養したバチルス・サブティリス(Bacillus subtilis)株を回収し、まず、遠心分離器で菌株と活性培地とに分離する。1.0%の生理食塩水を利用して菌株を3回洗浄した後、微生物の適切な代謝のために発酵液を供給する。前記発酵液は、発酵液の総重量に対して2.5重量%の砂糖を混合して製造する。次に、27psi(pounds per square inch)の圧力、120℃の温度で、15分間、高温加圧滅菌する。滅菌が完了した後、常温において25℃まで冷却する。前記洗浄工程において損傷を受けた菌株の発酵代謝の円滑化のために、菌株を発酵液中で安定化させる過程に供される。具体的には、食塩水で3回洗浄した菌株を、大豆粉末を加える前の発酵液300mlに混合し、培養器で24時間培養して安定化させる。
[Example 1] Production of fermented tea A Bacillus subtilis strain cultured for 72 hours at 30 ° C. using a vibration incubator is recovered, and first separated into a strain and an active medium using a centrifuge. . After washing the strain three times using 1.0% saline, the fermentation broth is supplied for proper metabolism of the microorganism. The fermentation broth is produced by mixing 2.5% sugar by weight with respect to the total weight of the fermentation broth. Next, it is autoclaved at a pressure of 27 psi (pounds per square inch) and a temperature of 120 ° C. for 15 minutes. After sterilization is complete, cool to 25 ° C at room temperature. In order to facilitate fermentation metabolism of the strain damaged in the washing step, the strain is subjected to a process of stabilizing the strain in the fermentation broth. Specifically, the bacterial strain washed 3 times with saline is mixed with 300 ml of the fermented liquid before the soybean powder is added, and is cultured and stabilized for 24 hours in an incubator.

滅菌した反応タンク内において、小包装に分けた緑茶成分を、バチルス・サブティリスを発酵液に接種した発酵菌液と混合し、発酵菌株の数が10〜10CFU/mlとなるように調節する。緑茶茶葉の乾燥重量を基準にして、発酵液の割合は30〜60重量%となるように混合する。また、急激な温度上昇によって菌株が損傷を受けないように、発酵菌液を混合した後にも、茶葉を引き続き撹拌して茶の内部温度が急速に上がらないようにする。20分後、反応が完了し、温度が下がった緑茶発酵菌液混合物は、入口を塞いで外気の流入を防ぎ、発酵工程に供される。発酵工程は、60℃の恒温発酵槽で7日間実施する。発酵工程が完了した後、80〜120℃で5時間熱風乾燥することにより、発酵茶を製造する。 In the sterilized reaction tank, the green tea components divided into small packages are mixed with the fermented bacterial solution inoculated with Bacillus subtilis into the fermented solution so that the number of fermenting strains is 10 3 to 10 8 CFU / ml. Adjust. Based on the dry weight of green tea leaves, mixing is performed so that the ratio of the fermented liquid is 30 to 60% by weight. Also, in order to prevent the strain from being damaged by a rapid temperature rise, the tea leaves are continuously stirred even after mixing the fermented bacterial solution so that the internal temperature of the tea does not rise rapidly. After 20 minutes, the reaction is completed and the temperature of the green tea fermented bacterial solution mixture is blocked by closing the inlet to prevent the inflow of outside air and is subjected to the fermentation process. The fermentation process is carried out in a constant temperature fermentor at 60 ° C. for 7 days. After the fermentation process is completed, fermented tea is produced by hot-air drying at 80 to 120 ° C. for 5 hours.

前記方法により製造された発酵茶は、病原性微生物が検出されず、最終製品内の総菌数(Total microbial account)が10CFU/g以下の規格範囲の製品を得ることができる。 In the fermented tea produced by the above method, pathogenic microorganisms are not detected, and a product in the standard range in which the total number of bacteria in the final product (Total microbiological account) is 10 2 CFU / g or less can be obtained.

[実施例2]飲用条件
前記実施例1において製造した発酵茶を1gずつに量り分けて、ティーバッグを製造する。紙コップにティーバッグを入れて熱湯を注いで5分間放置する。ティーバッグを5回浸した後、被検者に対し右手で持って飲用させるようにした。1杯の量は一般的な紙コップの80%を満たすことができる量に設定する。
[Example 2] Drinking conditions 1 g of fermented tea produced in Example 1 is weighed to produce a tea bag. Put a tea bag in a paper cup, pour hot water and leave it for 5 minutes. After immersing the tea bag 5 times, the subject was allowed to drink with his right hand. The amount of one cup is set to an amount that can fill 80% of a general paper cup.

[実験例1]ヒトの手の温度低下の改善
普段から手足が冷たいと感じる韓国人女性を対象にして、本発明に係る発酵茶の試料を茶の形態で飲用した後、赤外線カメラで手と足を撮影した。撮影結果を基に、試料の摂取前と摂取1時間後の手の皮膚温度の変化を比較した。赤外線撮影(digital infrared thermographic imaging, DITI)は、人体や物体から放射される赤外線を測定してイメージ化するもので、身体表面の体温分布を知ることができる非侵襲的な撮影方法である。実験終了後に設問用紙を被験者に配布し、試料の品質と効能に関する設問調査を実施した。
[Experimental Example 1] Improvement of temperature drop in human hands For Korean women who usually feel cold in their hands and feet, after drinking the fermented tea sample according to the present invention in the form of tea, I photographed my feet. Based on the imaging results, changes in skin temperature of the hand before and 1 hour after the sample were compared. Infrared imaging (digital infrared thermographic imaging, DITI) is a non-invasive imaging method that measures infrared rays emitted from a human body or an object to make an image, and can know the body temperature distribution on the body surface. After the experiment was completed, a questionnaire was distributed to the subjects, and a survey on the quality and efficacy of the sample was conducted.

一つの試料当たり30名の被験者を対象に評価した。評価前に各被験者は、手を洗浄し、空気の移動や直射日光のない恒温恒湿の条件(22℃、湿度45%)が保たれた空間において1時間以上安静を取るようにした。被験者の左手の甲を測定部位とし、評価中は手の温度変化を誘発するような姿勢は避けるようにした。   Thirty subjects were evaluated per sample. Prior to the evaluation, each subject washed his hands and was allowed to rest for more than 1 hour in a space maintained at constant temperature and humidity (22 ° C., humidity 45%) without air movement or direct sunlight. The back of the subject's left hand was taken as the measurement site, and during the evaluation, postures that induced temperature changes in the hand were avoided.

赤外線カメラを利用して60cmの距離から手を撮影し、皮膚の放射率は0.98に設定した。撮影時は温度に影響を与え得る外部物質を遮断した状態とし、試料摂取前と、試料摂取直後、15分後、30分後、45分後、60分後の時点で撮影を実施した。温かいコップを手に持つことで表われ得る温度の変化を防止するために、コップは右手で持つようにし、左手を撮影した。飲用条件は、実施例2と同一の条件に設定した。   A hand was photographed from a distance of 60 cm using an infrared camera, and the skin emissivity was set to 0.98. At the time of photographing, an external substance capable of affecting the temperature was blocked, and photographing was performed before taking the sample, and immediately after taking the sample, 15 minutes, 30 minutes, 45 minutes, and 60 minutes later. In order to prevent changes in temperature that could be manifested by holding a warm cup in the hand, the cup was held with the right hand and the left hand was photographed. The drinking conditions were set to the same conditions as in Example 2.

測定データの分析は、FLIR Reporter(スウェーデンのFlir社の商標)プログラムを利用して、一定面積の皮膚温度を分析した。すなわち、各被験者の手の同じ場所を選んで、指定された面積の平均温度値を分析した。試料摂取前の測定温度を基準値0とし、温度の増減を表示するために試料摂取前と試料摂取後の皮膚温度の差を求め、対照群(水)との間の統計的有意性を検証した。実験群は、実施例1に係る発酵茶を使用し、比較群は、非発酵茶である緑茶を使用した。   Analysis of the measurement data was performed using the FLIR Reporter (trademark of Fir, Sweden) program to analyze the skin temperature of a certain area. That is, the same place of each subject's hand was selected and the average temperature value of the designated area was analyzed. The measured temperature before sample intake is set to the reference value 0, and the difference between the skin temperature before sample intake and after sample intake is calculated to display the increase and decrease in temperature, and statistical significance between the control group (water) is verified. did. The experimental group used fermented tea according to Example 1, and the comparative group used green tea, which is non-fermented tea.

時間経過に伴う温度増減の結果を図1に示し、赤外線撮影写真を図2に示した。図2において、手の色が濃いほど、その温度が高いことを意味する。
図1を参照すると、対照群である水摂取群は、試料摂取直後に最も大きい温度低下を示し、15分経過時点以降から持続的に温度が低下することが分かる。緑茶摂取群は、一時的に温度が上昇したが、15分経過時点以降に最も急激な温度低下を示した。これに比べ、発酵茶摂取群は、時間の経過に伴って最も緩やかな温度低下を示した。
The results of temperature increase / decrease with the passage of time are shown in FIG. 1, and infrared photographs are shown in FIG. In FIG. 2, the darker the color of the hand, the higher the temperature.
Referring to FIG. 1, the water intake group, which is a control group, shows the greatest temperature decrease immediately after sample intake, and it can be seen that the temperature continuously decreases after 15 minutes. The green tea intake group temporarily increased in temperature, but showed the most rapid temperature decrease after 15 minutes. In comparison, the fermented tea intake group showed the most gradual temperature drop over time.

また、図2において、発酵茶摂取時には、比較的温度が低い指の先端まで濃い色で表示されることを確認することができた。これは、発酵茶摂取群の手の温度低下が最もよく阻止されていることを意味する。したがって、発酵茶は、手の皮膚温度が低下するのを阻止することにより、手の冷えといった手足冷え性の症状に優れた効果があることが分かる。   In FIG. 2, it was confirmed that when fermented tea was ingested, a dark color was displayed up to the tip of the finger having a relatively low temperature. This means that the temperature drop in the hands of the fermented tea intake group is best prevented. Therefore, it can be seen that fermented tea has an excellent effect on symptoms of cold hands and feet such as cold hands by preventing the skin temperature of the hands from decreasing.

[実験例2]ヒトの足の温度低下の改善
普段から手足が冷たいと感じる韓国人女性を対象にして、本発明に係る発酵茶の試料を茶の形態で飲用した後、赤外線カメラで手と足を撮影した。撮影結果を基に、試料の摂取前と摂取1時間後の手の皮膚温度の変化を比較した。測定方法は、前記実験例1と同一の条件と方法で行った。
[Experimental example 2] Improvement of temperature drop of human foot For Korean women who usually feel cold in their limbs, after drinking the fermented tea sample according to the present invention in the form of tea, I photographed my feet. Based on the imaging results, changes in skin temperature of the hand before and 1 hour after the sample were compared. The measurement method was performed under the same conditions and method as in Experimental Example 1.

一つの試料当たり30名の被験者を対象に評価した。評価前に各被験者は、足を洗浄し、空気の移動や直射日光のない恒温恒湿の条件(22℃、湿度45%)が保たれた空間において1時間以上安静を取るようにした。被験者の両足の甲を測定部位とし、評価中は足の温度変化を誘発するような姿勢は避けるようにした。   Thirty subjects were evaluated per sample. Prior to the evaluation, each subject washed his / her feet and was allowed to rest for more than 1 hour in a space maintained at constant temperature and humidity (22 ° C., humidity 45%) without air movement and direct sunlight. The insteps of both feet of the subject were used as measurement sites, and postures that induced temperature changes in the feet were avoided during the evaluation.

赤外線カメラを利用して100cmの距離から足を撮影し、皮膚の放射率は0.98に設定した。撮影時は温度に影響を与え得る外部物質を遮断した状態とし、試料摂取前と、試料摂取直後、15分後、30分後、45分後、60分後の時点で撮影を実施した。飲用条件は実施例2と同一の条件に設定した。   The foot was photographed from a distance of 100 cm using an infrared camera, and the skin emissivity was set to 0.98. At the time of photographing, an external substance capable of affecting the temperature was blocked, and photographing was performed before taking the sample, and immediately after taking the sample, 15 minutes, 30 minutes, 45 minutes, and 60 minutes later. The drinking conditions were set to the same conditions as in Example 2.

前記実験例1と同様に、各被験者の両足の同じ場所を選んで、指定された面積の平均温度値を分析した。試料摂取前の測定温度を基準値0とし、温度の増減を表示するために試料摂取前と試料摂取後の皮膚温度の差を求め、対照群(水)との間の統計的有意性を検証した。実験群は、実施例1に係る発酵茶を使用し、比較群は、非発酵茶である緑茶を使用した。   Similar to Experimental Example 1, the same place on both feet of each subject was selected and the average temperature value of the designated area was analyzed. The measured temperature before sample intake is set to the reference value 0, and the difference between the skin temperature before sample intake and after sample intake is calculated to display the increase and decrease in temperature, and statistical significance between the control group (water) is verified. did. The experimental group used fermented tea according to Example 1, and the comparative group used green tea, which is non-fermented tea.

時間経過に伴う温度増減の結果を図3に示し、赤外線撮影写真を図4に示した。図4において、足先の色が濃いほど、その温度が低いことを意味する。
図3を参照すると、水摂取群は、持続的かつ最も急激に足の温度が低下しており、緑茶摂取群もまた、類似な様相で足の温度が低下することを確認した。これに比べ、発酵茶摂取群は、試料摂取後に最も小さい温度低下を示し、特に、摂取後30分が経過した後の温度維持効果が最も高いことが観察された。また、図4において、発酵茶摂取群の足先の色が最も薄いことを確認することができ、これは、発酵茶摂取群の足の温度低下の程度が最も低いことを意味する。
The result of the temperature increase / decrease with the passage of time is shown in FIG. 3, and the infrared photograph is shown in FIG. In FIG. 4, the darker the color of the foot, the lower the temperature.
Referring to FIG. 3, it was confirmed that the water temperature of the water intake group decreased most rapidly and most rapidly, and the green tea intake group also decreased the temperature of the foot in a similar manner. Compared with this, the fermented tea intake group showed the smallest temperature drop after sample ingestion, and in particular, the highest temperature maintenance effect after 30 minutes after ingestion was observed. Moreover, in FIG. 4, it can confirm that the color of the toe of a fermented tea ingestion group is the lightest, and this means that the grade of the temperature fall of the leg of a fermented tea ingestion group is the lowest.

したがって、本発明の一側面に係る発酵茶は、足の皮膚温度が低下するのを阻止することにより、足の冷えといった手足冷え性の症状に優れた効果があることが分かる。
[実験例3]発酵茶の摂取による嗜好感調査
前記実施例1により製造された緑茶の発酵茶を飲用した後、嗜好感についての調査を行った。飲用条件は、実施例2と同一であった。設問項目には、足及び身体が温まるかどうか、摂取後の腹痛又は排便感の変化の有無、香り、及び全般的な満足度等が含まれ、製品が市販された場合に購買する意思の有無についても質問した。各項目について肯定的な回答をまとめて、その結果を図5に示した。
Therefore, it can be seen that the fermented tea according to one aspect of the present invention has an excellent effect on the symptoms of cold limbs such as cold feet by preventing the skin temperature of the feet from decreasing.
[Experimental Example 3] Preference Survey by Ingestion of Fermented Tea After drinking the green tea fermented tea produced in Example 1, a survey was conducted on preference. The drinking conditions were the same as in Example 2. Questions include whether the feet and body are warmed, whether there is a change in abdominal pain or defecation after ingestion, scent, and general satisfaction, etc. Whether the product will be purchased when the product is marketed Also asked about. The positive answers for each item are summarized and the results are shown in FIG.

図5に示された結果を参照すると、本発明に係る発酵茶を摂取した場合には、緑茶を摂取した場合と比較して、足が温まったという回答が高いことが示され、発酵茶を摂取した後における腹痛又は排便感の変化は最も低いことが確認された。特に、香りに優れるという回答が高いことが示され、全般的な満足度もまた悪くないことが明らかになった。   Referring to the results shown in FIG. 5, when the fermented tea according to the present invention was ingested, it was shown that the answer that the foot was warmed was higher than when the green tea was ingested. It was confirmed that the change in abdominal pain or defecation after ingestion was the lowest. In particular, it was shown that the answer of being excellent in fragrance was high, and it became clear that overall satisfaction was not bad either.

本発明による発酵茶抽出物含有組成物は、以下のとおり、様々な剤形に応用可能であるが、これらに限定されるものではない。
[製造例1]軟質カプセル剤
発酵茶抽出物100mg、大豆抽出物50mg、大豆油180mg、紅蔘抽出物50mg、パーム油2mg、パーム硬化油8mg、黄蝋4mg及びレシチン6mgを混合し、常法に従い、1カプセル当たり400mgずつ充填して軟質カプセルを製造した。
The fermented tea extract-containing composition according to the present invention can be applied to various dosage forms as follows, but is not limited thereto.
[Production Example 1] Soft capsule 100 mg of fermented tea extract, 50 mg of soybean extract, 180 mg of soybean oil, 50 mg of red yeast rice extract, 2 mg of palm oil, 8 mg of hardened palm oil, 4 mg of yellow wax and 6 mg of lecithin According to the above, 400 mg per capsule was filled to produce soft capsules.

[製造例2]錠剤
発酵茶抽出物100mg、大豆抽出物50mg、ブドウ糖100mg、紅蔘抽出物50mg、澱粉96mg及びマグネシウムステアレート4mgを混合し、30%エタノールを40mg添加して顆粒を形成した後、60℃で乾燥し、打錠機を利用して錠剤に打錠した。
[Production Example 2] Tablet After mixing fermented tea extract 100 mg, soybean extract 50 mg, glucose 100 mg, red yeast rice extract 50 mg, starch 96 mg and magnesium stearate 4 mg, and adding 40 mg of 30% ethanol to form granules , Dried at 60 ° C. and compressed into tablets using a tableting machine.

[製造例3]顆粒剤
発酵茶抽出物100mg、大豆抽出物50mg、ブドウ糖100mg、紅蔘抽出物50mg及び澱粉600mgを混合し、30%エタノールを100mg添加して顆粒を形成した後、60℃で乾燥して顆粒を形成した後、包みに充填した。内容物の最終重量は1gとした。
[製造例4]ドリンク剤
発酵茶抽出物100mg、大豆抽出物50mg、ブドウ糖10g、紅蔘抽出物50mg、クエン酸2g及び精製水187.8gを混合してドリンク剤を製造した後、壜に充填した。内容物の最終容量は200mlとした。
[Production Example 3] Granules 100 mg of fermented tea extract, 50 mg of soybean extract, 100 mg of glucose, 50 mg of red yeast rice extract and 600 mg of starch were mixed, and 100 mg of 30% ethanol was added to form granules, and then at 60 ° C. After drying to form granules, the packets were filled. The final weight of the contents was 1 g.
[Production Example 4] Drink preparation After preparing a drink preparation by mixing 100 mg of fermented tea extract, 50 mg of soybean extract, 10 g of glucose, 50 mg of red yeast rice extract, 2 g of citric acid and 187.8 g of purified water, the drink is filled. did. The final volume of the contents was 200 ml.

Claims (11)

茶(tea)に、醤類由来の菌株を接種して得られた発酵茶。   Fermented tea obtained by inoculating tea (tea) with a strain derived from soy sauce. 前記茶(tea)は、緑茶、白茶、烏龍茶、紅茶、プーアル茶、黒茶及び柿葉茶により構成される群から選択される一つ以上である、請求項1に記載の発酵茶。   The fermented tea according to claim 1, wherein the tea is at least one selected from the group consisting of green tea, white tea, oolong tea, black tea, puer tea, black tea, and kashiwa tea. 前記醤類由来の菌株は、バチルス・サブティリス(Bacillus subtilis)、バチルス・リケニフォルミス(Bacillus licheniformis)、バチルス・メガテリウム(Bacillus megateriums)、バチルス・ナットウ(Bacillus natto)、バチルス・シトレウス(Bacillus citreus)、バチルス・サーキュランス(Bacillus circulans)、バチルス・メセンテリカス(Bacillus mesentericus)及びバチルス・プミルス(Bacillus pumilus)により構成される群から選択される一つ以上の菌株である、請求項1に記載の発酵茶。   The soy sauce-derived strains are Bacillus subtilis, Bacillus licheniformis, Bacillus megaterus, Bacillus natto, Bacillus natto, The fermented tea according to claim 1, which is one or more strains selected from the group consisting of Bacillus circulans, Bacillus mesentericus and Bacillus pumilus. 前記茶(tea)は、緑茶であり、前記醤類由来の菌株は、バチルス・サブティリス(Bacillus subtilis)である、請求項1に記載の発酵茶。   The fermented tea according to claim 1, wherein the tea is green tea and the soy-derived strain is Bacillus subtilis. 茶(tea)含有発酵液を製造する工程;
製造された発酵液に、醤類由来の菌株を接種する工程;及び
菌株が接種された発酵液を発酵させる工程を含む、発酵茶の製造方法。
Producing a tea-containing fermentation broth;
A method for producing fermented tea, comprising a step of inoculating a produced fermentation broth with a strain derived from soy sauce; and a step of fermenting a fermentation broth inoculated with the strain.
前記茶(tea)は、緑茶、白茶、烏龍茶、紅茶、プーアル茶、黒茶及び柿葉茶により構成される群から選択される一つ以上である、請求項5に記載の発酵茶の製造方法。   The method for producing fermented tea according to claim 5, wherein the tea is one or more selected from the group consisting of green tea, white tea, oolong tea, black tea, puer tea, black tea, and kashiwa tea. . 前記醤類由来の菌株は、バチルス・サブティリス(Bacillus subtilis)、バチルス・リケニフォルミス(Bacillus licheniformis)、バチルス・メガテリウム(Bacillus megateriums)、バチルス・ナットウ(Bacillus natto)、バチルス・シトレウス(Bacillus citreus)、バチルス・サーキュランス(Bacillus circulans)、バチルス・メセンテリカス(Bacillus mesentericus)及びバチルス・プミルス(Bacillus pumilus)により構成される群から選択される一以上の菌株である、請求項5に記載の発酵茶の製造方法。   The soy sauce-derived strains are Bacillus subtilis, Bacillus licheniformis, Bacillus megaterus, Bacillus natto, Bacillus natto, The method for producing fermented tea according to claim 5, which is one or more strains selected from the group consisting of Bacillus circulans, Bacillus mesentericus, and Bacillus pumilus. . 菌株が接種された発酵液を発酵させる工程は、20〜70℃の温度で、24時間〜28日間発酵させる工程である、請求項5に記載の発酵茶の製造方法。   The method for producing fermented tea according to claim 5, wherein the step of fermenting the fermentation broth inoculated with the strain is a step of fermenting at a temperature of 20 to 70 ° C. for 24 hours to 28 days. 菌株が接種された発酵液を発酵させる工程は、40〜60℃の温度で発酵させる工程である、請求項8に記載の発酵茶の製造方法。   The method for producing fermented tea according to claim 8, wherein the step of fermenting the fermentation broth inoculated with the strain is a step of fermenting at a temperature of 40 to 60 ° C. 請求項1〜4のいずれか一項に記載の発酵茶の抽出物を含む、血液循環改善用組成物。   The composition for blood circulation improvement containing the extract of the fermented tea as described in any one of Claims 1-4. 請求項1〜4のいずれか一項に記載の発酵茶の抽出物を含む、手足冷え性改善用組成物。   A composition for improving the cooling of hands and feet, comprising the extract of fermented tea according to any one of claims 1 to 4.
JP2012534120A 2009-10-15 2010-10-15 Composition for improving blood circulation and improving cooling of hands and feet containing fermented tea extract Active JP6355887B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2009-0098051 2009-10-15
KR1020090098051A KR101698919B1 (en) 2009-10-15 2009-10-15 Composition Containing Extract of Fermentated Tea for Improving Circulation of Blood and Mitigating Cold Symptoms in Hands and Feet
PCT/KR2010/007092 WO2011046392A2 (en) 2009-10-15 2010-10-15 Composition for improving blood circulation and alleviating cold hands and feet, containing fermented tea extract

Publications (2)

Publication Number Publication Date
JP2013507912A true JP2013507912A (en) 2013-03-07
JP6355887B2 JP6355887B2 (en) 2018-07-11

Family

ID=43876729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534120A Active JP6355887B2 (en) 2009-10-15 2010-10-15 Composition for improving blood circulation and improving cooling of hands and feet containing fermented tea extract

Country Status (5)

Country Link
US (1) US10080375B2 (en)
JP (1) JP6355887B2 (en)
KR (1) KR101698919B1 (en)
CN (1) CN102647913B (en)
WO (1) WO2011046392A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101838588B1 (en) * 2010-12-09 2018-03-16 (주)아모레퍼시픽 Composition Containing Extract of Fermentated Tea for Reducing Lipid Level
KR101381950B1 (en) * 2013-01-28 2014-04-07 명지대학교 산학협력단 Fermented tea of persimmon leaf and manufacturing method of the same
US20160330991A1 (en) * 2014-02-17 2016-11-17 Ito En, Ltd. Tea leaves and process for producing same
CN103789243B (en) * 2014-02-21 2015-10-07 怀化学院 One bacillus pumilus and application thereof
KR102323969B1 (en) * 2014-03-21 2021-11-09 (주)아모레퍼시픽 Composition comprising extract post-fermented tea
WO2015142098A1 (en) * 2014-03-21 2015-09-24 (주)아모레퍼시픽 Composition comprising fermented tea extract
CN105076550B (en) * 2015-09-09 2019-01-29 古吉生物科技(大连)有限公司 Preparation method of enzyme tea for secondary fermentation
KR101925960B1 (en) * 2016-12-30 2018-12-06 서울대학교 산학협력단 Composition containing plant extract for preventing, treating and improving the suffering from cold hadns and feet
KR102132127B1 (en) * 2019-11-01 2020-07-09 이경원 Fish and Shellfish Fishy Removal Method and Processed Food By the Method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10191930A (en) * 1997-01-13 1998-07-28 Toshiyuki Ota Healthy material
JPH11276072A (en) * 1998-03-27 1999-10-12 Bio Tec Japan:Kk Fermented material of green tea and food and drink utilizing the same
JP2002034554A (en) * 2000-07-28 2002-02-05 Mitsukan Group Honsha:Kk Bacillus natto producing vitamin k at high concentration, method for breeding the same and fermented soybean
JP2006254837A (en) * 2005-03-18 2006-09-28 Kyoto Institute Of Technology Lactic acid bacterium functional tea, lactic acid bacterium functional tea extract and dried product of lactic acid bacterium functional tea leaf
JP2007044014A (en) * 2005-08-12 2007-02-22 Amano Jitsugyo Kk Dried food containing lactobacillus sporogenes derived from fermented food
WO2008105432A1 (en) * 2007-02-27 2008-09-04 Mizkan Group Corporation Natto bacterium capable of producing reduced amount of ammonia, method for production of natto using the natto bacterium, and natto
JP2008239504A (en) * 2007-03-26 2008-10-09 Flora:Kk Method for producing catechin derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010086193A (en) * 2000-02-14 2001-09-10 허경만 Hematic green tea and method for preparation thereof
ATE373716T1 (en) * 2000-11-28 2007-10-15 Henkel Kgaa CYCLODEXTRIN GLUCANOTRANSFERASE (CG TASE) FROM BACILLUS AGARADHERENS (DSM 9948) AND DETERGENT AND CLEANING PRODUCT WITH THIS NEW CYCLODEXTRIN GLUCANOTRANSFERASE
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
KR100625829B1 (en) * 2004-09-06 2006-09-20 김동원 A cheonggukjang containing green tee extract and the manufacturing method therof
JP2007306872A (en) * 2006-05-19 2007-11-29 Suntory Ltd Proanthocyanidin-containing tea beverage
KR100849232B1 (en) * 2007-01-11 2008-07-31 주식회사 엔유씨전자 The functional fermented products increased fibrinolytic activity and fermentation method thereof
KR20080110004A (en) * 2007-06-14 2008-12-18 강성국 Korea mold to fermentation greentea
CN101107955B (en) * 2007-08-24 2010-12-01 游文龙 Health-care puer ripe tea and preparing method thereof
KR100975199B1 (en) * 2007-11-30 2010-08-10 (주)아모레퍼시픽 Method for manufacturing fermented green tea, and green tea therefrom
CN101467568A (en) 2007-12-28 2009-07-01 胡徐玉 Method for producing fermented tea using microorganism
CN101263853B (en) * 2008-04-25 2012-07-04 北京市科威华食品工程技术有限公司 Gingko green tea fermentation health care beverage

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10191930A (en) * 1997-01-13 1998-07-28 Toshiyuki Ota Healthy material
JPH11276072A (en) * 1998-03-27 1999-10-12 Bio Tec Japan:Kk Fermented material of green tea and food and drink utilizing the same
JP2002034554A (en) * 2000-07-28 2002-02-05 Mitsukan Group Honsha:Kk Bacillus natto producing vitamin k at high concentration, method for breeding the same and fermented soybean
JP2006254837A (en) * 2005-03-18 2006-09-28 Kyoto Institute Of Technology Lactic acid bacterium functional tea, lactic acid bacterium functional tea extract and dried product of lactic acid bacterium functional tea leaf
JP2007044014A (en) * 2005-08-12 2007-02-22 Amano Jitsugyo Kk Dried food containing lactobacillus sporogenes derived from fermented food
WO2008105432A1 (en) * 2007-02-27 2008-09-04 Mizkan Group Corporation Natto bacterium capable of producing reduced amount of ammonia, method for production of natto using the natto bacterium, and natto
JP2008239504A (en) * 2007-03-26 2008-10-09 Flora:Kk Method for producing catechin derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6015000105; お茶で体を温めよう:冷え性改善ネット , 2008 *
JPN6015000107; 日々向上 , 20080628 *

Also Published As

Publication number Publication date
US20120201805A1 (en) 2012-08-09
KR20110041050A (en) 2011-04-21
US10080375B2 (en) 2018-09-25
CN102647913B (en) 2015-06-10
CN102647913A (en) 2012-08-22
JP6355887B2 (en) 2018-07-11
WO2011046392A2 (en) 2011-04-21
KR101698919B1 (en) 2017-01-23
WO2011046392A3 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
JP6355887B2 (en) Composition for improving blood circulation and improving cooling of hands and feet containing fermented tea extract
JP6737779B2 (en) Method for producing microbial preparation and microbial preparation produced thereby
TWI354701B (en)
CN102791849B (en) Lactic acid bacterium-containing preparation
CN108883127A (en) Lactobacteria-containing composition of packet for preventing and treating vaginopathy and application thereof
WO2021177526A1 (en) Breast milk-derived lactobacillus reuteri lm1071 strain having excellent safety and intestinal adhesiveness, and composition comprising strain or cultured product thereof
EP2991659B1 (en) Lachnospiraceae in the gut microbiota and association with body weight
JP7280069B2 (en) A composition for preventing or improving functional gastrointestinal disorders, and pharmaceutical compositions and food and drink compositions using the composition for preventing or improving functional gastrointestinal disorders
CN106132427A (en) Compositions containing after fermentation tea extract
CN106212675A (en) A kind of tea flavour flavored fermented milk and preparation method thereof
KR102606952B1 (en) Method of Lactobacillus Plantarum TWK10 composition for improving inflammation or reducing body fat after exercise
KR101687982B1 (en) Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof
CN109123622A (en) A kind of conditioning health rose fermentation ferment and preparation method thereof
US20120052056A1 (en) Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same
JP2014503515A (en) Composition for reducing lipid level comprising fermented tea extract
US20100285176A1 (en) Fermentation product of aloe, method of manufacturing the same and functional foods using the same
JP2023554512A (en) Non-stop production process of encapsulated probiotics with improved viability, heat resistance, storage stability and in-body stability of lactic acid bacteria freeze-drying using matrix capsule protective film natural generation technology
JP4336930B2 (en) Method for producing lactic acid bacteria fermentation broth and food made from the fermentation broth
CN105802876A (en) Composite probiotic-fermented alfalfa sprout powder preparation and preparation method and application thereof
CN108887667A (en) A kind of ferment adjusting female incretion
CN106119065A (en) A kind of Hericium erinaceus (Bull. Ex Fr.) Pers. jujube vinegar and preparation method and application
CN109430476A (en) Tea ferment drink and preparation method thereof with defaecation ease constipation function
CN115702001A (en) Composition for suppressing or improving depression
KR20180040906A (en) A composition comprising poly-gamma glutamic acid for protecting and treating vaginosis disease and the use thereof
CN108991115A (en) A kind of fermented type synbiotic goat milk piece and preparation method thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130909

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140526

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150113

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150410

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160420

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160523

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20160722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170607

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171212

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180613

R150 Certificate of patent or registration of utility model

Ref document number: 6355887

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250